Acadian Asset Management LLC Adma Biologics, Inc. Transaction History
Acadian Asset Management LLC
- $34.5 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
346Shares Held
181MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$399 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$389 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$318 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$242 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$118 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.2B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...